.Nature Medication, Released online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Standpoint requires inclusion of individuals along with MASLD and also dimension of liver end results in cardio-- renal-- metabolic trials, when information recommend mechanistically possible perks and also scientific security-- and also summarizes considerations for test design and governing approval.